PI
ENTA icon

Putnam Investments’s Enanta Pharmaceuticals ENTA Stock Holding History

Putnam Investments’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-29,501
Closed -$330K – 1179
2023
Q3 		$330K Sell
29,501
-255
-0.9% -$4.11K ﹤0.01% 1051
2023
Q2 		$637K Sell
29,756
-929
-3% -$27.4K ﹤0.01% 891
2023
Q1 		$1.24M Sell
30,685
-1,299
-4% -$62K ﹤0.01% 830
2022
Q4 		$1.49M Sell
31,984
-18
-0.1% -$821 ﹤0.01% 775
2022
Q3 		$1.66M Sell
32,002
-11,001
-26% -$643K ﹤0.01% 778
2022
Q2 		$2.03M Buy
43,003
+16,293
+61% +$884K ﹤0.01% 728
2022
Q1 		$1.9M Sell
26,710
-2,026
-7% -$132K ﹤0.01% 807
2021
Q4 		$2.15M Buy
+28,736
New +$2.26M ﹤0.01% 752
2015
Q4 		– Sell
-42,278
Closed -$1.53M – 1456
2015
Q3 		$1.53M Buy
42,278
+1,087
+3% +$46.7K ﹤0.01% 1066
2015
Q2 		$1.85M Buy
41,191
+15,798
+62% +$615K ﹤0.01% 1086
2015
Q1 		$777K Sell
25,393
-891
-3% -$34.7K ﹤0.01% 1242
2014
Q4 		$1.34M Sell
26,284
-143
-0.5% -$6.4K ﹤0.01% 1139
2014
Q3 		$1.05M Buy
26,427
+466
+2% +$18.6K ﹤0.01% 1194
2014
Q2 		$1.12M Buy
25,961
+32
+0.1% +$1.22K ﹤0.01% 1167
2014
Q1 		$1.04M Buy
+25,929
New +$942K ﹤0.01% 1190

Other funds holding ENTA

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Putnam Investments's ENTA Position: Q4 2023 in Review

Putnam Investments sold out of Enanta Pharmaceuticals (ENTA) in Q4 2023, closing a stake of 29,501 shares — an estimated $330K sold.

Putnam Investments first reported a position in ENTA in Q1 2014 and held it in 15 quarters. The position peaked at $2.15M in Q4 2021. 106 funds tracked by Wall St. Rank hold ENTA as of Q4 2023.

  • Putnam Investments reported no remaining Enanta Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Putnam Investments sold 29,501 Enanta Pharmaceuticals shares in Q4 2023, an estimated $330K.
  • Putnam Investments first reported a position in Enanta Pharmaceuticals in Q1 2014 and held it in 15 quarters.
  • Putnam Investments's Enanta Pharmaceuticals position peaked at $2.15M in Q4 2021.
  • 106 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.